CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 4 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,841,175 | +47.3% | 157,500 | +69.4% | 0.35% | +52.6% |
| Q2 2023 | $1,249,920 | -18.9% | 93,000 | 0.0% | 0.23% | -5.0% |
| Q1 2023 | $1,541,940 | +33.7% | 93,000 | +50.0% | 0.24% | +28.7% |
| Q4 2022 | $1,153,200 | +45.1% | 62,000 | 0.0% | 0.19% | +37.2% |
| Q3 2022 | $795,000 | -12.7% | 62,000 | -52.3% | 0.14% | -12.7% |
| Q2 2022 | $911,000 | +61.5% | 130,000 | +91.2% | 0.16% | +42.7% |
| Q1 2022 | $564,000 | +22.6% | 68,000 | 0.0% | 0.11% | +8.9% |
| Q4 2021 | $460,000 | -30.0% | 68,000 | -45.2% | 0.10% | -30.3% |
| Q3 2021 | $657,000 | -7.9% | 124,000 | 0.0% | 0.14% | -2.0% |
| Q2 2021 | $713,000 | – | 124,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 252,199 | $749,000 | 2.35% |
| MANGROVE PARTNERS IM, LLC | 3,031,965 | $9,005,000 | 1.14% |
| ARMISTICE CAPITAL, LLC | 10,000,000 | $29,700,000 | 1.08% |
| GABLES CAPITAL MANAGEMENT INC. | 432,864 | $1,286,000 | 0.83% |
| Worth Venture Partners, LLC | 268,682 | $798,000 | 0.66% |
| XTX MARKETS LLC | 18,749 | $56,000 | 0.27% |
| Capital Impact Advisors, LLC | 203,133 | $603,000 | 0.18% |
| Wealthspire Advisors, LLC | 337,770 | $1,003,000 | 0.06% |
| ROYCE & ASSOCIATES LP | 1,784,890 | $5,301,000 | 0.06% |
| XML Financial, LLC | 40,000 | $119,000 | 0.04% |